Sarah J. Byrnes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sarah J. Byrnes has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Melissa J. Churchill
ATRACT Research Centre, School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT) University, Bundoora West Campus, Melbourne, Australia
2 shared publications - Thomas A. Angelovich
ATRACT Centre, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia
2 shared publications - Anna C. Hearps
Disease Elimination Program, Burnet Institute, Australia
1 shared publication - Emily K. Chalmers
ATRACT Leading Research Centre, School of Health and Biomedical Sciences, RMIT University, Melbourne 3000, Australia
1 shared publication - Janna Jamal Eddine
ATRACT Leading Research Centre, School of Health and Biomedical Sciences, RMIT University, Melbourne 3000, Australia
1 shared publication - Jessica J. Kivinen
ATRACT Centre, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia
1 shared publication
Latest Publications
- Open Access
Impact of HIV on Neuronal Health in the Brains of People with HIV
Despite effective viral suppression with antiretroviral therapy (ART), people with HIV (PWH) remain at increased risk of neurocognitive impairment and persistent neuroinflammation. Although neurons are not infected by HIV, they remain susceptible to the indirect effects of chronic infection, including exposure to viral proteins, inflammatory mediators, and glial dysfunction. The resulting neuronal injury is thought to contribute to the development and persistence of HIV-associated neurocognitive disorders in the ART era. This review examines the impact of chronic HIV infection on neuronal function, highlighting mechanisms of neuronal dysfunction driven by both viral-dependent and viral-independent pathways. We discuss the role of central nervous system viral reservoirs, neuroimmune interactions, and the neurotoxic effects of HIV proteins including Tat, gp120, and Nef. We further explore how chronic HIV infection influences synaptic integrity, neuronal metabolism, and age-related neurodegeneration. Finally, we highlight emerging biomarkers and therapeutic strategies aimed at preserving neuronal function. By integrating current evidence on both viral-dependent and viral-independent mechanisms of neuronal dysfunction, this review identifies critical knowledge gaps and future research priorities aimed at preserving neuron function and improving neurological outcomes in PWH.
Open AccessImpact of HIV on Neuronal Health in the Brains of People with HIV
Despite effective viral suppression with antiretroviral therapy (ART), people with HIV (PWH) remain at increased risk of neurocognitive impairment and persistent neuroinflammation. Although neurons are not infected by HIV, they remain susceptible to the indirect effects of chronic infection, including exposure to viral proteins, inflammatory mediators, and glial dysfunction. The resulting neuronal injury is thought to contribute to the development and persistence of HIV-associated neurocognitive disorders in the ART era. This review examines the impact of chronic HIV infection on neuronal function, highlighting mechanisms of neuronal dysfunction driven by both viral-dependent and viral-independent pathways. We discuss the role of central nervous system viral reservoirs, neuroimmune interactions, and the neurotoxic effects of HIV proteins including Tat, gp120, and Nef. We further explore how chronic HIV infection influences synaptic integrity, neuronal metabolism, and age-related neurodegeneration. Finally, we highlight emerging biomarkers and therapeutic strategies aimed at preserving neuronal function. By integrating current evidence on both viral-dependent and viral-independent mechanisms of neuronal dysfunction, this review identifies critical knowledge gaps and future research priorities aimed at preserving neuron function and improving neurological outcomes in PWH.
- Open Access
- 31 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3185
HIV Promoters Isolated from Brain and Peripheral Tissue of Virally Suppressed PWH Are Phylogenetically and Functionally Similar
Despite viral suppression with antiretroviral therapy (ART), reservoirs of Human Immunodeficiency Virus (HIV) persist in anatomical compartments throughout the body, including the brain. We have previously demonstrated that the HIV long terminal repeats (LTRs) isolated from the brains of non-virally suppressed people with HIV (PWH) are phylogenetically and functionally distinct from those isolated from matched peripheral tissue. While intact, transcriptionally competent HIV genomes persist within the brains of virally suppressed PWH, whether HIV LTRs are intact, functional, and compartmentalized relative to the periphery, as in non-virally suppressed PWH, remains unclear. HIV LTRs were extracted from frontal cortex post-mortem brain and matched peripheral tissues of virally suppressed PWH (n = 5). Following single-genome amplification, sequences were phylogenetically analyzed and transcriptional activity was assessed. In contrast to non-virally suppressed PWH, LTR sequences failed to compartmentalize between the brain and peripheral compartments. Identical LTR sequences were observed across brain and peripheral tissues in 2/5 PWH. While the LTRs remain transcriptionally active, mutations, insertions and deletions predicted to reduce transcription factor binding affinity at key binding sites, including C/EBP, NF-κB, and Sp1 sites, were observed and found to result in reduced basal transcriptional activity. The role of these mutations in latency and viral persistence remains unclear.
- 31 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3185
Open AccessHIV Promoters Isolated from Brain and Peripheral Tissue of Virally Suppressed PWH Are Phylogenetically and Functionally Similar
Despite viral suppression with antiretroviral therapy (ART), reservoirs of Human Immunodeficiency Virus (HIV) persist in anatomical compartments throughout the body, including the brain. We have previously demonstrated that the HIV long terminal repeats (LTRs) isolated from the brains of non-virally suppressed people with HIV (PWH) are phylogenetically and functionally distinct from those isolated from matched peripheral tissue. While intact, transcriptionally competent HIV genomes persist within the brains of virally suppressed PWH, whether HIV LTRs are intact, functional, and compartmentalized relative to the periphery, as in non-virally suppressed PWH, remains unclear. HIV LTRs were extracted from frontal cortex post-mortem brain and matched peripheral tissues of virally suppressed PWH (n = 5). Following single-genome amplification, sequences were phylogenetically analyzed and transcriptional activity was assessed. In contrast to non-virally suppressed PWH, LTR sequences failed to compartmentalize between the brain and peripheral compartments. Identical LTR sequences were observed across brain and peripheral tissues in 2/5 PWH. While the LTRs remain transcriptionally active, mutations, insertions and deletions predicted to reduce transcription factor binding affinity at key binding sites, including C/EBP, NF-κB, and Sp1 sites, were observed and found to result in reduced basal transcriptional activity. The role of these mutations in latency and viral persistence remains unclear.